FTC: Amgen-Horizon Deal Would Cement Monopoly For Treatment Of Two Diseases
Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commissions promised campaign to protect competition in the...
United States Holly Vedova Emisar Pharma Services Kellogg Eye Center Humana Pharmacy Solutions Inc American Thyroid Association
Source: marketscreener.com